IVF/Fertility company with leading clinical reputation and performance.  Partnered  with UK-based  Nobel prize winning inventors of the procedure

Investment Rationale

Building a fast growing and profitable fertility/IVF business, based on a collaboration with one of the leading IVF companies in the world, Bourn Hall Clinic, UK: Clinical and Technology leadership combined with brand credibility and recognition meets unmet clinical demand.

Investment dateJuly 2010
Exit datePartial exit 2018, Full exit November 2021– Read the Exit Announcement
SectorIVF, Assisted Reproduction
Investment typeGreenfield

Business Highlights and Impact

  • Conceptualized the UAE business in 2010 with the management of Bourn Hall Clinic, UK, to provide quality access to IVF/Fertilty services in the UAE
  • Business plan creation and syndicated financing for the business in 2010
  • Applied ESG Framework
  • In late 2018, Mediclinic Middle East bought a 30% stake and provided increased market access
  • Structured transaction with Mediclinic in late 2018 which resulted in expansion and growth across the UAE
  • Entering the year 2021, the company in 2021 was a leader in clinical performance in the UAE, full exit in November 2021